公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2021 | Measurement of uracil-DNA glycosylase activity by matrix assisted laser desorption/ionization time-of-flight mass spectrometry technique | Chang, Hui-Lan; KANG-YI SU ; Goodman, Steven D; Yen, Rong-Syuan; WERN-CHERNG CHENG ; YA-CHIEN YANG ; LIANG-IN LIN ; SUI-YUAN CHANG ; WOEI-HORNG FANG | DNA repair | 5 | 5 | |
2019 | Metabolomics Investigation of Voriconazole-Induced Hepatotoxicity in Mice | Wu S.-L.; Wei T.-Y.; SHU-WEN LIN ; KANG-YI SU ; CHING-HUA KUO | Chemical Research in Toxicology | 13 | 13 | |
2007 | Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory | KANG-YI SU ; Chien W.-L.; WEN-MEI FU ; Yu I.-S.; HSIANG-PO HUANG ; PEI-HSIN HUANG ; Lin S.-R.; JIN-YUAN SHIH ; Lin Y.-L.; Hsueh Y.-P.; PAN-CHYR YANG ; SHU-WHA LIN | Journal of Neuroscience | 76 | 74 | |
2023 | MiR-503 pleiotropically regulates epithelial-mesenchymal transition and targets PTK7 to control lung cancer metastasis | TZU-HSIU TSAI ; Gow, Chien-Hung; Liu, Yi-Nan; Tsai, Meng-Feng; Chang, Tzu-Hua; SHANG-GIN WU ; MIN-SHU HSIEH ; KANG-YI SU ; JIN-YUAN SHIH | Cancer medicine | 0 | 0 | |
2016 | Molecular gene signature and prognosis of non-small cell lung cancer | Huang P.; Cheng C.-L.; Chang Y.-H.; Liu C.-H.; Hsu Y.-C.; JIN-SHING CHEN ; Chang G.-C.; Ho B.-C.; KANG-YI SU ; Chen H.-Y.; SUNG-LIANG YU | Oncotarget | 17 | 16 | |
2018 | Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma | KANG-YI SU ; Tseng J.-S.; Liao K.-M.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; PAN-CHYR YANG ; SUNG-LIANG YU ; Chang G.-C. | PLoS ONE | 17 | 13 | |
2022 | Novel Genetic Prognostic Signature for Lung Adenocarcinoma Identified by Differences in Gene Expression Profiles of Low- and High-Grade Histological Subtypes | Chang, Chia-Ching; MIN-SHU HSIEH ; MONG-WEI LIN ; Lee, Yi-Hsuan; Hsiao, Yi-Jing; KANG-YI SU ; Su, Te-Jen; SUNG-LIANG YU ; JIN-SHING CHEN | Biomolecules | 3 | 4 | |
2018 | Novel therapeutic drug identification and gene correlation for fatty liver disease using high-content screening: Proof of concept | Luo W.-J.; Cheng T.-Y.; Wong K.-I.; WOEI-HORNG FANG ; Liao K.-M.; Hsieh Y.-T.; KANG-YI SU | European Journal of Pharmaceutical Sciences | 9 | 9 | |
2018 | Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study | CHIA-CHI LIN ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHAO-CHI HO ; WEI-YU LIAO ; JIH-HSIANG LEE ; TZU-HSIU TSAI ; KANG-YI SU ; MIN-SHU HSIEH ; YIH-LEONG CHANG ; Bai Y.-Y.; DE-RUI HUANG ; Thress K.S.; CHIH-HSIN YANG | The Lancet Respiratory Medicine | 120 | 109 | |
2022 | PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients | Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Chen, Jeremy J W; Huang, Yen-Hsiang; Chang, Gee-Chen | Scientific reports | 11 | 9 | |
2019 | Perinatal polychlorinated biphenyls and polychlorinated dibenzofurans exposure are associated with DNA methylation changes lasting to early adulthood: Findings from Yucheng second generation | KANG-YI SU ; Li M.-C.; Lee N.-W.; Ho B.-C.; Cheng C.-L.; Chuang Y.-C.; SUNG-LIANG YU ; Yue Leon Guo | Environmental Research | 17 | 15 | |
2013 | Potential therapeutic role of hispidulin in gastric cancer through induction of apoptosis via NAG-1 signaling | Yu C.Y.; KANG-YI SU ; Lee P.-L.; Jhan J.-Y.; Tsao P.-H.; Chan D.-C.; Chen Y.-L.S. | Evidence-based Complementary and Alternative Medicine | 35 | 31 | |
2012 | Potential therapeutic role of Z-isochaihulactone in lung cancer through induction of apoptosis via notch signaling | Ou J.-P.; Lin H.-Y.; KANG-YI SU ; SUNG-LIANG YU ; Tseng I.-H.; Chen C.-J.; Hsu H.-C.; Chan D.-C.; Sophia Chen Y.-L. | Evidence-based Complementary and Alternative Medicine | 15 | 13 | |
2016 | Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patients | Huang Y.-H.; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; KANG-YI SU ; Chen H.-Y.; Chang C.-S.; Chen J.J.W.; SUNG-LIANG YU ; HUEI-WEN CHEN ; Yang T.-Y.; Chang G.-C. | Journal of Thoracic Disease | 2 | 2 | |
2012 | Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer | KANG-YI SU ; Chen H.-Y.; Li K.-C.; Kuo M.-L.; CHIH-HSIN YANG ; Chan W.-K.; Ho B.-C.; Chang G.-C.; JIN-YUAN SHIH ; SUNG-LIANG YU ; PAN-CHYR YANG | Journal of Clinical Oncology | 462 | 428 | |
2021 | Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment | Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Zheng, Zhe-Rong; Yang, Tsung-Ying; Chen, Kun-Chieh; Huang, Yen-Hsiang; KANG-YI SU ; SUNG-LIANG YU ; Chang, Gee-Chen | Oncology | 9 | 9 | |
2014 | Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma | Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; CHONG-JEN YU ; WEI-YU LIAO ; Tsai, Chi-Ren; Tsai, Meen-Hsin; SUNG-LIANG YU ; KANG-YI SU ; Chen, Jeremy Jw; Chen, Hsuan-Yu; MONG-HSUN TSAI | OncoTargets and Therapy | 15 | 14 | |
2021 | Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan | SHANG-GIN WU ; WEI-YU LIAO ; KANG-YI SU ; SUNG-LIANG YU ; YEN-LIN HUANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | JTO Clinical and Research Reports | 16 | 0 | |
2018 | Proofreading and DNA repair assay using single nucleotide extension and MALDI-TOF mass spectrometry analysis | KANG-YI SU ; Goodman S.D.; Lai H.-M.; Yen R.-S.; Hu W.-Y.; WERN-CHERNG CHENG ; LIANG-IN LIN ; YA-CHIEN YANG ; WOEI-HORNG FANG | Journal of Visualized Experiments | 4 | 4 | |
2020 | Proofreading of single nucleotide insertion/deletion replication errors analyzed by MALDI-TOF mass spectrometry assay | Chang, Hui Lan; KANG-YI SU ; Goodman, Steven D.; Chou, Neng An; Lin, Kuei Ching; WERN-CHERNG CHENG ; LIANG-IN LIN ; SUI-YUAN CHANG ; WOEI-HORNG FANG | DNA Repair | 1 | 1 | |